See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!
Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
Chemical Class · NSAIDS
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords | Interest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70620 |
6- |
23981-47-7 | >99% |
|
2.614227542459 | 6-methoxy-naphthalene-acetic-acid | 6-MNA | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits | 2.614227542459 | |||
| 70260 | Aspirin | 50-78-2 | >99% |
|
2.845864352549 | aspirin | Acetylsalicylic Acid | atherosclerosis cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits | 2.845864352549 | |||
| 10010153 |
Aspirin™ Effect- |
- |
|
2007-06-08 | 64.708784700907 | aspirin-effect-detection-kit | use:human 11-dehydro-TXB2 enzyme immunoassays ELISAs kits measures metabolites atherosclerosis thromboxanes eias analysistools:eia atherosclerosis cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits atherosclerosis assays | 64.708784700907 | ||||
| 10277 |
ATB- |
912758-00-0 | ≥98% |
|
2008-11-11 | 5.087592435188 | atb-337 | ACS 15; S-Diclofenac | inflammation H2S NSAIDs indomethacin gastric damage leukocytes hydrogen sulfides gasotransmitter vasodilator atb337 ACS-15 ACS15 ACS S SDiclofenac Diclofenac | 5.087592435188 | ||
| 13045 |
ATB- |
1000700-26-4 | ≥98% |
|
✓ | 2008-11-09 | 2.921846578835 | atb-343 | inflammation H2S NSAIDs indomethacin gastric damage leukocytes hydrogen sulfide gasotransmitter vasodilator atb343 | 2.921846578835 | ||
| 70210 | CAY10404 | - | >98% |
|
33.684031102925 | cay10404 | COX-2 inhibitors PGHS-2 COX2 PGHS2 prostaglandins synthases NSAIDS selective selectivity inhibits inhibition cyclooxygenase | 33.684031102925 | ||||
| 70680 | Diclofenac (sodium salt) | 15307-79-6 | ≥99% |
|
18.282537685014 | diclofenac-sodium-salt | Voltaren; Ecofenac; Benfofen | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits | 18.282537685014 | |||
| 70250 |
(±)- |
5104-49-4 | ≥99% |
|
52.414400450173 | -flurbiprofen | Ansaid | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases neurochemistry synthase-1 synthase-2 inhibits 51543-38-5 | 52.414400450173 | |||
| 70280 |
(±)- |
15687-27-1 | ≥99% |
|
25.678516286251 | -ibuprofen | Motrin | PPAR cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits peroxisome proliferator-activated receptors neurochemistry | 25.678516286251 | |||
| 70270 | Indomethacin | 53-86-1 | ≥99% |
|
29.233316340602 | indomethacin | Indocin | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin synthases synthase-1 synthase-2 PPARs peroxisome proliferator-activated receptors inhibits neurochemistry | 29.233316340602 | |||
| 10006661 | Ketoprofen | 22071-15-4 | ≥98% |
|
2005-05-18 | 13.119212991383 | ketoprofen | 2-(3-benzoylphenyl)propionic Acid; Oruvail; Orudis | COX cyclooxygenases NSAIDS nonsteroidal non-steroidal anti-inflammatory drugs prostaglandins PGs inflammations pain racemates racemic R-enantiomers cytokines non-selective inhibits inhibitor inhibition | 13.119212991383 | ||
| 9001148 | Ketorolac New | 74103-06-3 | ≥98% |
|
2012-01-12 | 12.447457304307 | ketorolac | Sprix®; Acular PF®; RS 37619; Acular LS® | analgesic NSAIDs COX inhibition inhibits inhibitors ocular pain inflammation PGE2 non steroidal anti-inflammatory antiinflammatory drugs heteroaryl acetic acids derivatives cyclooxygenase opthalmalic solutions ocular COX-1 COX-2 COX1 COX2 racemic 66635-83-4 | 12.447457304307 | ||
| 70690 | Ketorolac (tromethamine salt) | 74103-07-4 | >99% |
|
30.135208034922 | ketorolac-tromethamine-salt | Toradol | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits | 30.135208034922 | |||
| 10007672 | LDL Receptor Blocking Peptide | - | 2007-05-03 | 14.513259668508 | ldl-receptor-blocking-peptide | Low-density Lipoprotein Receptor Blocking peptide; LDLR Blocking Peptide | proteins diseases WB western blots blotting ICC immunocytochemistry cholesterols cells membranes lipoproteins low density receptors LDLRs glycoproteins blood regulates plasma ligands binding domains EGF O-link sugars membrane-spanning regions cytoplasmic livers hormonal controls mutations familial hypercholesterolemia atherosclerosis mouse murine N- SDS-PAGE unglycosylated HepG2 RAW 264.7 | 14.513259668508 | ||||
| 10005705 |
NO- |
301838-28-8 | >98% |
|
✓ | 2004-10-20 | 5.517237569061 | no-indomethacin | NCX 2121 | inhibition inhibitors NSAIDs non-steroidal anti-inflammatory drugs inhibits nitric oxides cancer chemopreventative donor gastrointestinal NOs PaCa-2 PaCa2 pancreatic analgesic | 5.517237569061 | |
| 70590 |
NS- |
123653-11-2 | >98% |
|
140.299861878453 | ns-398 | cyclooxygenases inhibitors NSAIDs COX-2 nonsteroidal anti-inflammatory drugs cox2 pghs2 pghs-2 prostaglandins synthases synthase-2 inhibits selective ns398 selectivity neurochemistry | 140.299861878453 | ||||
| 70400 | Phenylbutazone | 50-33-9 | >99% |
|
9.224254143646 | phenylbutazone | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits PGIS | 9.224254143646 | ||||
| 13368 | Piroxicam | 36322-90-4 | ≥95% |
|
2010-01-06 | 3.501417463240 | piroxicam | NSC 666076; Larapam; Feldene | inflammation NSAIDs inhibitors cyclooxygenases COX-1 COX-2 analgesic pain arthritis cancers Artrooxicam Baxo Bruxicam CP 16171 Geldene Neoxicam Reudene Roxicam Roxiden Sasulen Solocalm Uphaxicam Zunden inhibition inhibited inflammatory Piroxicam CP-16171 CP 16171 Feldene CP16171 | 3.501417463240 | ||
| 10006973 | Pravadoline | 92623-83-1 | ≥98% |
|
2011-02-08 | 49.868317154124 | pravadoline | WIN 48,098 | Anti-inflammatory analgesic COX inhibitors pain AAI NSAIDs inhibits inhibition prostaglandins PGs synthesis murine inhibited mouse cyclooxygnases opoid Indoles receptors WIN48098 WIN-48098 WIN 48098 WIN-48,8098 | 49.868317154124 | ||
| 70255 |
(R)- |
51543-40-9 | ≥99% |
|
2004-06-11 | 8.886160220994 | -r-flurbiprofen | E-7869; Tarenflurbil; Flurizan | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits inhibition neurochemistry | 8.886160220994 | ||
| 10004207 |
(S)- |
51543-39-6 | ≥99% |
|
2004-06-11 | 12.827425414365 | -s-flurbiprofen | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits inhibition (S)Flurbiprofen | 12.827425414365 | |||
| 70290 |
(S)- |
22204-53-1 | >99% |
|
21.061152445263 | -s-naproxen | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits | 21.061152445263 | ||||
| 10004386 | Sulindac | 38194-50-2 | >98% |
|
2004-04-20 | 9.961476934269 | sulindac | NSAIDS anti-inflammatory inhibitors inhibits cancer COX non-steroidal nonsteroidal drugs cyclooxygenases indomethacin pghs2 cox2 pghs-2 prostaglandin synthases synthase-2 | 9.961476934269 | |||
| 70480 | Tolfenamic Acid | 13710-19-5 | >99% |
|
10.637108655617 | tolfenamic-acid | Clotam | cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits calcium influx | 10.637108655617 |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2012 Cayman Chemical Company
Quick Search